Antibody Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Kits, Chemical and Reagents, Consumables); Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, Others); End-User (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies), and Geography.
The Antibody Testing Market was valued at US$ 6,415.90 million in 2019 and is projected to reach US$ 10,740.69 million by 2027; it is expected to grow at a CAGR of 6.7% from 2020 to 2027.
Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests.
The scope of the Antibody Testing market includes procedure Antibody Testing products, indication, end user and region. The market for Antibody Testing is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the Antibody Testing market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Lucrative Regions for Antibody Testing Market
Get more information on this report :
Market Insights
Rising Number of COVID-19 Cases across the World.
Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures to be taken. Antibody testing is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.
Antibody detection kits are predictive for prognosis and detection of COVID-19 infections to assist the diseases. Since these kits help examine whether a person has developed antibodies in their bloodstream to fight the SARS-CoV-2, it indicates whether a person has been exposed to or has COVID-19. In order to manage the COVID-19 pandemic and increase patient screening, several companies are offering these rapid antibody detection kits to healthcare workers, hospitals, laboratories, and other professionals. Thus, rising incidence of coronavirus cases and growing government approvals for antibody test kits are the few factors responsible for the growth of the market.
Antibody Testing Products -Based Insights
Global Antibody Testing Market, based on Antibody Testing Products, the Antibody Testing market is segmented into Kits, Chemical and Reagents, Consumables. In 2019, the Kits segment accounted for the highest share of the market. Growth of this segment is attributed to large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and higher adoption of kits in various research processes. The same segment is likely to register highest CAGR in the global Antibody Testing market during the forecast period.
Global Antibody Testing Market, by Indication – 2019 & 2027
Get more information on this report :
Indication-Based Insights
Global Antibody Testing Market, based on indication, the Antibody Testing market is segmented into pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases, others. The infectious diseases segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 8.0% in the market during the forecast period.
End User – Based Insights
Global Antibody Testing Market, based on End User, the Antibody Testing market is segmented into Hospitals, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies. The Diagnostic Laboratories segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 7.4% in the market during the forecast period.
COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade. Till date no definitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run Antibody Testing market will have significant growth prospects as many market players has received emergency use authorization for their newly developed antibody tests. All such developments will add up to the future demand for antibody testing market.
Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategies are commonly adopted by the market players in order to expand its product portfolio.
The market players operating in the Antibody Testing Market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
By Product
- Kits,
- Chemical and Reagents,
- Consumables
By Indication
- Pregnancy,
- Cardiovascular Diseases,
- Autoimmune Diseases,
- Infectious Diseases,
- Oncology,
- Endocrine Diseases,
- Others
By End User
- Hospitals,
- Academic and Research Institutes,
- Diagnostic Laboratories,
- Biopharmaceutical Companies
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of the Europe
- Asia Pacific(APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South America (SAM)
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Thermo Fisher Scientific
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Beckton, Dickinson And Company
- F. Hoffmann La Roche
- Agilent Technologies
- DiaSorin
- Zeus Scientific
- Abcam
- Trinity Biotech
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Antibody Testing Market – By Product
1.3.2 Antibody Testing Market – By Indication
1.3.3 Antibody Testing Market – By End User
1.3.4 Global Antibody Testing Market – By Geography
2. Antibody Testing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Antibody Testing Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America– PEST Analysis
4.3 Expert Opinions
5. Antibody Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Number of COVID-19 Cases Worldwide
5.1.2 Increasing Prevalence of Chronic Diseases
5.1.3 Growing Geriatric Population
5.2 Market Restraints
5.2.1 Limitations of Antibody Screening Tests
5.3 Market Opportunities
5.3.1 Collaborative & Innovation-Driven Strategies
5.3.2 Growth of Healthcare Sector in Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories
5.5 Impact Analysis
6. Antibody Testing Market – Global Analysis
6.1 Global Antibody Testing Marker Revenue Forecast and Analysis
6.2 Global Antibody Testing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Antibody Testing Market Analysis and Forecasts to 2027 Product
7.1 Overview
7.2 Global Antibody Testing, by Product, 2019 & 2027 (% Share)
7.3 Kits
7.3.1 Overview
7.3.2 Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
7.3.3 Serological Test Kits
7.3.3.1 Overview
7.3.3.2 Serological Test Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
7.3.4 Immunoglobulin Kits
7.3.4.1 Overview
7.3.4.2 Immunoglobulin Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
7.3.5 Lateral Flow Assay Kits
7.3.5.1 Overview
7.3.5.2 Lateral Flow Assay Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Chemical and Reagents
7.4.1 Overview
7.4.2 Global Chemical and Reagents Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Consumables
7.5.1 Overview
7.5.2 Global Consumables Market Revenue and Forecast to 2027 (US$ Mn)
8. Antibody Testing Market Analysis – By Indication
8.1 Overview
8.2 Antibody Testing Market Revenue Share, by Indication (2019 and 2027)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Endocrine Diseases
8.4.1 Overview
8.4.2 Endocrine Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Oncology
8.5.1 Overview
8.5.2 Oncology: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Cardiovascular Diseases
8.6.1 Overview
8.6.2 Cardiovascular Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Pregnancy
8.7.1 Overview
8.7.2 Pregnancy: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Autoimmune Diseases
8.8.1 Overview
8.8.2 Autoimmune Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Other Diseases
8.9.1 Overview
8.9.2 Other Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
9. Antibody Testing Market – By End-User
9.1 Overview
9.2 Antibody Testing Market, by End-User, 2019 and 2027 (%)
9.3 Diagnostic Laboratories
9.3.1 Overview
9.3.2 Global Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Hospitals
9.4.1 Overview
9.4.2 Global Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Biopharmaceutical Companies
9.5.1 Overview
9.5.2 Biopharmaceutical Companies: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Academic Research Institutes
9.6.1 Overview
9.6.2 Academic Research Institutes: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
10. Antibody Testing Market Analysis and Forecasts To 2027 Geographical Analysis
10.1 North America: Antibody Testing Market
10.1.1 Overview
10.1.2 North America: Antibody Testing Market, - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.1.3.1 North America: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Antibody Testing Market, by Country, 2019 & 2027 (%)
10.1.7 US: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.7.5 US: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.8.5 Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.1.9.5 Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Antibody Testing Market
10.2.1 Overview
10.2.2 Europe: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Antibody Testing Market, by Product – Revenue and Forecast to 2027(USD Million)
10.2.3.1 Europe: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Antibody Testing Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.7.2.1 Germany: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.8.2.1 UK: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UK: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.9.2.1 France: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.10.2.1 Spain: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.11.2.1 Italy: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.2.12 Rest of Europe: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.1 Rest of Europe: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.2 Rest of Europe: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.12.2.1 Rest of Europe: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.12.3 Rest of Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.2.12.4 Rest of Europe: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Antibody Testing Market
10.3.1 Overview
10.3.2 Asia Pacific: Antibody Testing Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia-Pacific: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.3.1 Asia-Pacific: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia-Pacific: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia-Pacific: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Antibody Testing Market, by Country, 2019 & 2027 (%)
10.3.7 China: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.7.3.1 China: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.7.5 China: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.8.2.1 Japan: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.9.2.1 India: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.10.2.1 South Korea: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.11.2.1 Australia: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.3.12 Rest of Asia Pacific: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.12.1 Rest of Asia Pacific: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.3.12.2 Rest of Asia Pacific: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.3.12.2.1 Rest of Asia Pacific: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.12.3 Rest of Asia Pacific: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.3.12.4 Rest of Asia Pacific: Antibody Testing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Antibody Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Antibody Testing Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.4.3.1 Middle East & Africa: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Antibody Testing Market, by Indication– Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Antibody Testing Market, by End User– Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa Antibody Testing Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.7.5 Saudi Arabia Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.8.5 UAE: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.9.5 South Africa Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.10 Rest of Middle East and Africa: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East & Africa Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.4.10.3 Rest of Middle East & Africa: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.10.4 Rest of Middle East & Africa: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
10.4.10.5 Rest of Middle East & Africa: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Antibody Testing Market
10.5.1 Overview
10.5.2 South and Central America: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.5.3.1 South and Central America: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America: Antibody Testing Market, by Indication– Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Antibody Testing Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil: Antibody Testing Market, by Indication– Revenue and Forecast to 2027 (USD Million)
10.5.7.5 Brazil: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina: Antibody Testing Market, by Indication– Revenue and Forecast to 2027 (USD Million)
10.5.8.5 Argentina: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.9 Rest of South and Central America: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.1 Rest of South and Central America: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.2 Rest of South and Central America: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.5.9.3 Rest of South and Central America: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.9.4 Rest of South and Central America: Antibody Testing Market, by Indication– Revenue and Forecast to 2027 (USD Million)
10.5.9.5 Rest of South and Central America: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Antibody Testing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Abbott
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 F. HOFFMANN-LA ROCHE LTD.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Agilent Technologies, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 DiaSorin S.p.A.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ZEUS Scientific
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ABCAM
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Trinity Biotech
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Total Number of Persons Aged 60 Years or Above – by Region, 2017 & 2050
Table 2. North America: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. US: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 9. US: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 18. Europe: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 19. Europe: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 21. Europe: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 22. Prevalence of diabetes and related risk factors in Germany:
Table 23. Germany: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 24. Germany: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 25. Germany: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 26. Germany: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 27. Cancer Statistics for the UK
Table 28. UK: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 29. UK: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 30. UK: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 31. UK: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 32. France: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 33. France: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 34. France: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 35. France: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 36. Spain: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 37. Spain: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 38. Spain: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 39. Spain: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 40. Italy: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 41. Italy: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Italy: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 43. Italy: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 45. Rest of Europe: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 46. Rest of Europe: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 47. Rest of Europe: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 48. Asia-Pacific: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 49. Asia-Pacific: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 50. Asia-Pacific: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 51. Asia-Pacific: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 52. Incidence rate of cancer in 2019 in China
Table 53. China: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 54. China: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 55. China: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 56. China: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 57. Japan: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 58. Japan: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 59. Japan: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 60. Japan: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 61. India: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 62. India: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 63. India: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 64. India: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 65. South Korea: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 66. South Korea: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 67. South Korea: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 68. South Korea: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 69. Australia: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 70. Australia: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 71. Australia: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 72. Australia: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 73. Rest of Asia Pacific: Antibody Testing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 74. Rest of Asia Pacific: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 75. Rest of Asia Pacific: Antibody Testing Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 76. Rest of Asia Pacific: Antibody Testing Market, by End-User– Revenue and Forecast to 2027 (USD Million)
Table 77. Middle East & Africa Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 78. Middle East & Africa: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 79. Middle East & Africa Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 80. Middle East & Africa Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 81. Saudi Arabia Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 82. Saudi Arabia: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 83. Saudi Arabia Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 84. Saudi Arabia Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 85. UAE: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 86. UAE: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 87. UAE: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 88. UAE: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 89. South Africa Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 90. South Africa: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 91. South Africa Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million
Table 92. South Africa Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 93. Rest of Middle East & Africa: Antibody Testing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 94. Rest of Middle East & Africa: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 95. Rest of Middle East & Africa: Antibody Testing Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 96. Rest of Middle East & Africa: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 97. South and Central America: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 98. South and Central America: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 99. South and Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
Table 100. South and Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 101. Brazil: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 102. Brazil: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 103. Brazil: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
Table 104. Brazil: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 105. Argentina: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 106. Argentina: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 107. Argentina: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
Table 108. Argentina: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 109. Rest of South and Central America: Antibody Testing Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 110. Rest of South and Central America: Kits Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 111. Rest of South and Central America: Antibody Testing Market, by Indication- Revenue and Forecast to 2027 (USD Million)
Table 112. Rest of South and Central America: Antibody Testing Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 113. Organic Developments Done By Companies
Table 114. Inorganic Developments Done By Companies
Table 115. Glossary of Terms, Antibody Testing Market
LIST OF FIGURES
Figure 1. Antibody Testing Market Segmentation
Figure 2. Antibody Testing Market – By Geography
Figure 3. Antibody Testing Market Overview
Figure 4. Kits Product Segment Held Largest Share of Antibody Testing Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Antibody Testing Market, by Geography (US$ Million)
Figure 7. Global Antibody Testing Market – Leading Country Markets (US$ Million)
Figure 8. Global Antibody Testing Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Global Antibody Testing Market Impact Analysis of Driver and Restraints
Figure 15. Global Antibody Testing Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Antibody Testing Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Antibody Testing Market
Figure 18. Global Antibody Testing, By Product, 2019 & 2027 (% Share)
Figure 19. Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Serological Test Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Immunoglobulin Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Lateral Flow Assay Kits: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Global Chemical and Reagents Market Revenue and Forecast to 2027 (US$ Mn)
Figure 24. Global Consumables Market Revenue and Forecast to 2027 (US$ Mn)
Figure 25. Antibody Testing Market Revenue Share, by Indication (2019 and 2027)
Figure 26. Infectious Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Endocrine Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Most Prevalent Forms of Cancers Globally, 2018
Figure 29. Oncology: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Cardiovascular Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Pregnancy: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Autoimmune Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Other Diseases: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Antibody Testing Market, by End-User, 2019 and 2027 (%)
Figure 35. Global Diagnostic Laboratories Market Revenue And Forecast To 2027 (US$ Mn)
Figure 36. Global Hospitals Market Revenue And Forecast To 2027 (US$ Mn)
Figure 37. Biopharmaceutical Companies: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 38. Academic Research Institutes: Antibody Testing Market – Revenue and Forecast to 2027 (US$ Million)
Figure 39. North America: Antibody Testing Market, by Key Country – Revenue (2019) (USD Million)
Figure 40. North America: Antibody Testing Market, Revenue and Forecast to 2027 (USD Million)
Figure 41. North America: Antibody Testing Market, by Country, 2019 & 2027 (%)
Figure 42. US: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Canada: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Mexico: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Europe: Antibody Testing Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. Europe Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Europe: Antibody Testing Market, by Country, 2019 & 2027 (%)
Figure 48. Germany: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. UK: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. France: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Spain: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Italy: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Europe: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Asia Pacific: Antibody Testing Market, by Key Country – Revenue (2019) (USD Million)
Figure 55. Asia Pacific Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Asia Pacific: Antibody Testing Market, by Country, 2019 & 2027 (%)
Figure 57. China: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Japan: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. India: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. South Korea: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. Australia: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. Rest of Asia Pacific: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Middle East & Africa: Antibody Testing Market, by Key Country – Revenue (2019) (USD Million)
Figure 64. Middle East & Africa Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
Figure 65. Middle East & Africa: Antibody Testing Market, by Country, 2019 & 2027 (%)
Figure 66. Saudi Arabia: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. UAE: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 68. South Africa: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 69. Rest of Middle East and Africa: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 70. South and Central America: Antibody Testing Market, by Key Country – Revenue (2019) (USD Million)
Figure 71. South and Central America Antibody Testing Market Revenue and Forecast to 2027 (USD Million)
Figure 72. South and Central America: Antibody Testing Market, by Country, 2019 & 2027 (%)
Figure 73. Brazil: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 74. Argentina: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 75. Rest of South and Central America: Antibody Testing Market – Revenue and Forecast to 2027 (USD Million)
Figure 76. Impact of COVID-19 Pandemic in North American Country Markets
Figure 77. Impact of COVID-19 Pandemic in European Country Markets
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 79. Impact of COVID-19 Pandemic in Rest of the World Market
Figure 80. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Antibody Testing Market
- Thermo Fisher Scientific
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Beckton, Dickinson And Company
- F. Hoffmann La Roche
- Agilent Technologies
- DiaSorin
- Zeus Scientific
- Abcam
- Trinity Biotech
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Antibody Testing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global Antibody Testing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Frequently Asked Questions
An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests.
The factors that are driving growth of the market are rising number of COVID-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population are expected to boost the growth of the global Antibody Testing market.
The Antibody Testing market majorly consists of the players such as Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Inc., Beckton, Dickinson And Company, F. Hoffmann La Roche, Agilent Technologies, DiaSorin, Zeus Scientific, ABCAM, Trinity Biotech and among others.